Merck tried to patent a drug that would reduce heart attack risks for Vioxx (COX-2 selective inhibitors) users, three years before the company withdrew the painkiller drug from the market because of safety concerns. According to government records, the company applied for the patent in 2001. Merck voluntarily withdrew Vioxx, a $2.5 billion drug, on Sept. [...]
Merck tried to patent a drug that would reduce heart attack risks for Vioxx (COX-2 selective inhibitors) users, three years before the company withdrew the painkiller drug from the market because of safety concerns.
According to government records, the company applied for the patent in 2001. Merck voluntarily withdrew Vioxx, a $2.5 billion drug, on Sept. [...]
Please fill in the following fields
* - Required
Your Name: *
Your E-Mail: *
Your Remarks:
Friend's Name: *
Friend's E-Mail: *
